Human Papillomavirus Infection and Cervical Cancer Prevention in India, Bangladesh, Sri Lanka and Nepal

Vaccine

Volumn 26, Issue SUPPL. 12, 2008, Pages

  Sankaranarayanan, Rengaswamy ^a   Bhatla, Neerja ^b   Gravitt, Patti E ^c   Basu, Partha ^d   Esmy, Pulikattil O ^e   Ashrafunnessa, K S ^f   Ariyaratne, Yasantha ^g   Shah, Aarati ^h   Nene, Bhagwan M ⁱ  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^e Christian Fellowship Community Health Centre   (India)

^f BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^g Government Cancer Institute   (Sri Lanka)

^h Bhaktapur Cancer Care Centre   (Nepal)

ⁱ Nargis Dutt Memorial Cancer Hospital   (India)

Author keywords

Asia Pacific; Cancer control; Cervical screening; Cytology; Epidemiology; HPV; HPV testing; HPV vaccination; South Asia; Visual screening

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; WART VIRUS VACCINE;

ARTICLE; BANGLADESH; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; COLPOSCOPY; COST EFFECTIVENESS ANALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INDIA; NEPAL; PRIORITY JOURNAL; RISK FACTOR; SRI LANKA; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VACCINATION; VACCINE PRODUCTION; VIRUS DETECTION; VIRUS INFECTION;

ACETIC ACID; ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; BANGLADESH; FEMALE; HUMANS; INDIA; IODIDES; MASS SCREENING; MIDDLE AGED; NEPAL; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SRI LANKA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 50849083455     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.005     Document Type: Article

References (54)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon: IARC Press; 2004.
2. World Health Organization. Regional Office for South-East Asia. Available at: http://www.searo.who.int/ (last accessed: April 2008).
3. Curado MP, Edwards B, Shin HR, Strom H, Ferlay J, Heanue M, et al. Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publications No. 160. Lyon: IARC Press; 2007.
4. Cancer Atlas India. Available at: http://www.canceratlasindia.org/chapter6.asp (last accessed: April 2008)
5. World Health Organization. Reproductive health indicators database. Available at: http://www.who.int/reproductive-health/global_monitoring/RHRxmls/RHRmain page.htm (last accessed: April 2008)
6. Akther P.S., Uddin M.M., and Sharma S.K. Patterns of malignant neoplasma - a three years study. Bangladesh Med J 27 (1998) 29-32
7. Huq S.F. Common cancers of Bangladesh: Their trends through last three decades. Bangladesh Med J 17 (1988) 55-63
8. Franceschi S., Rajkumar R., Snijders P.J., Arslan A., Mahe C., Plummer M., et al. Papillomavirus infection in rural women in southern India. Br J Cancer 92 (2005) 601-606
9. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
10. Sankaranarayanan R., Nene B.M., Dinshaw K.A., Mahe C., Jayant K., Shastri S.S., et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 116 (2005) 617-623
11. Sankaranarayanan R., Chatterji R., Shastri S.S., Wesley R.S., Basu P., Mahe C., et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer 112 (2004) 341-347
12. Sowjanya A.P., Jain M., Poli U.R., Padma S., Das M., Shah K.V., et al. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis 5 (2005) 116
13. Laikangbam P., Sengupta S., Bhattacharya P., Duttagupta C., Dhabali S.T., Verma Y., et al. A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India. Int J Gynecol Cancer 17 (2007) 107-117
14. Franceschi S., Rajkumar T., Vaccarella S., Gajalakshmi V., Sharmila A., Snijders P.J., et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 107 (2003) 127-133
15. International Institute for Population Sciences (IIPS). National Family Health Survey (NFHS-3), India. 2005-2006. Ministry of Health and Family Welfare, Government of India. Available at: http://www.nfhsindia.org/pdf/IN.pdf (last accessed: April 2008)
16. Schensul S.L., Mekki-Berrada A., Nastasi B.K., Singh R., Burleson J.A., and Bojko M. Men's extramarital sex, marital relationships and sexual risk in urban poor communities in India. J Urban Health 83 (2006) 614-624
17. Munirajan A.K., Kannan K., Bhuvarahamurthy V., Ishida I., Fujinaga K., Tsuchida N., et al. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Gynecol Oncol 69 (1998) 205-209
18. Saranath D., Khan Z., Tandle A.T., Dedhia P., Sharma B., Contractor R., et al. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecol Oncol 86 (2002) 157-162
19. Bhatla N., Dar L., Patro A.R., Kriplani A., Gulati A., Verma K., et al. Human papillomavirus type distribution in cervical cancer in Delhi, India. Int J Gynecol Pathol 25 (2006) 398-402
20. Peedicayil A., Abraham P., Sathish N., John S., Shah K., Sridharan G., et al. Human papillomavirus genotypes associated with cervical neoplasia in India. Int J Gynecol Cancer 16 (2006) 1591-1595
21. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 (2003) 63-73
22. Bhatla N., Lal N., Bao Y.P., Ng T., and Qiao Y.L.A. meta-analysis of human papillomavirus type-distribution in women from South Asia: Implications for vaccination. Vaccine 26 23 (2008) 2811-2817
23. Aggarwal R., Gupta S., Nijhawan R., Suri V., Kaur A., Bhasin V., et al. Prevalence of high--risk human papillomavirus infections in women with benign cervical cytology: a hospital based study from North India. Indian J Cancer 43 3 (2006) 110-116
24. Arora R., Kumar A., Prusty B.K., Kailash U., Batra S., and Das B.C. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur J Obstet Gynecol Reprod Biol 121 1 (2005) 104-109
25. Ashrafunnessa K.S., Chowdhury T.A., Shamsuddin L., Islam M.N., and Hassan M.S. Human papillomavirus in cervical intraepithelial neoplasia in Bangladesh. Bangladesh J Obstet Gynaecol 20 (2005) 13-18
26. Ashrafunnessa K.S., Huq F., Islam M.N., Hassan M.S., and Aziz M.M. human papillomavirus in cervical cancer in Bangladesh. Bangladesh J Obstet Gynaecol 21 (2006) 52-57
27. de Silva R., Karunaratne K., Mendis L.N., Ramesh R., and Chow V.T. PCR detection and typing of human papilloma virus DNA in squamous carcinoma of the cervix in a cohort of Sri Lankan women. Ceylon Med J 51 (2006) 114-117
28. World Health Organization Vaccine Preventable Diseases Monitoring System. Available at: http://www.who.int/vaccines/globalsummary/immunization/countryprofilesel ect.cfm (last accessed: April 2008).
29. World Health Organization. World Health Survey, India. Available at: http://www.who.int/entity/healthinfo/survey/whsind-india.pdf (last accessed: April 2008).
30. Sankaranarayanan R., Nene B.M., Dinshaw K., Rajkumar R., Shastri S., wesley R., et al. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica Mex 45 Suppl 3 (2003) S399-S407
31. Parashari A., Singh V., Sehgal A., Satyanarayana L., Sodhani P., and Gupta M.M. Low-cost technology for screening uterine cervical cancer. Bull World Health Organ 78 (2000) 964-967
32. Londhe M., George S.S., and Seshadri L. Detection of CIN by naked eye visualization after application of acetic acid. Indian J Cancer 34 (1997) 88-91
33. Basu P.S., Sankaranarayanan R., Mandal R., Roy C., Das P., Choudhury D., et al. Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer 13 (2003) 626-632
34. Shastri S.S., Dinshaw K., Amin G., Goswami S., Patil S., Chinoy R., et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ 83 (2005) 186-194
35. Sankaranarayanan R., Basu P., Wesley R.S., Mahe C., Keita N., Mbalawa C.C., et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 110 (2004) 907-913
36. Sankaranarayanan R., Shastri S.S., Basu P., Mahe C., Mandal R., Amin G., et al. The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev 28 (2004) 345-351
37. Sankaranarayanan R., Thara S., Sharma A., Roy C., Shastri S., Mahe C., et al. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen 11 (2004) 77-84
38. Sankaranarayanan R., Gaffikin L., Jacob M., Sellors J., and Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 89 Suppl 2 (2005) S4-S12
39. Arbyn M., Sasieni P., Meijer C.J., Clavel C., Koliopoulos G., and Dillner J. Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses. Vaccine 24 Suppl 3 (2006) S78-S89
40. Sankaranarayanan R., Esmy P.O., Rajkumar R., Muwonge R., Swaminathan R., Shanthakumari S., et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 370 (2007) 398-406
41. Legood R., Gray A.M., Mahe C., Wolstenholme J., Jayant K., Nene B.M., et al. Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. Int J Cancer 117 (2005) 981-987
42. Sankaranarayanan R., Rajkumar R., Esmy P.O., Fayette J.M., Shanthakumary S., Frappart L., et al. Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer 96 (2007) 738-743
43. Sankaranarayanan R., Rajkumar R., Arrossi S., Theresa R., Esmy P.O., Mahe C., et al. Determinants of participation of women in a cervical cancer visual screening trial in rural south India. Cancer Detect Prev 27 (2003) 457-465
44. Nene B.M., Jayant K., Arrossi S., Shastri S., Budukh A., Hingmire S., et al. Determinants of womens participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ 85 (2007) 264-272
45. Goldie S.J., Gaffikin L., Goldhaber-Fiebert J.D., Gordillo-Tobar A., Levin C., Mahe C., et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353 (2005) 2158-2168
46. Dabash R., Vajpayee J., Jacob M., Dzuba I., Lal N., Bradley J., et al. A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India. Reprod Health 2 (2005) 11
47. Alliance for Cervical Cancer Prevention (ACCP). Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers. Seattle: ACCP; 2004.
48. World Health Organization. Comprehensive cervical cancer control. A guide to essential practice. Geneva: WHO; 2006.
49. Sankaranarayanan R, Wesley R. A Practical manual on visual screening for cervical neoplasia. IARC Technical Publication No. 41. Lyon: IARC Press; 2003.
50. Sellors J., and Sankaranarayanan R. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual (2003), IARC Press, Lyon
51. World Health Organization. World Health Survey, Bangladesh. Available at: http://www.who.int/entity/healthinfo/survey/whsbgd-bangladesh.pdf (last accessed: April 2008).
52. World Health Organization. World Health Survey, Sri Lanka. Available at: http://www.who.int/entity/healthinfo/survey/whslka-srilanka.pdf (last accessed: April 2008).
53. Bashyal R., and Dali S. Study on koilocytosis, X-chromatin and HSV-2 in cervical smears in Nepal. Nepal Med Coll J 6 (2004) 45-48
54. Pradhan P. Prevention of carcinoma cervix: role of Pap smear screening. Nepal Med Coll J 5 (2003) 82-86